Search Results for: 's viral clearance kits hcp immunoassays'

  • Cygnus Technologies products are used in the development and manufacturing of all types of biological drugs. These include monoclonal antibodies (mAbs) and recombinant proteins. The FDA began approving therapeutic monoclonal antibodies (mAbs) in 1986. Since then 79 therapeutic mAbs have been approved by FDA and are currently on the market [1].  Around the world, at least 570 therapeutic mAbs have been studied in clinical trials by commercial companies [2]. Uses for monoclonal antibodies include: ...
  • About Cygnus Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics. In addition, Cygnus now provides innovative viral clearance solutions as well.  Cygnus helps companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial rel...

2 Item(s)

per page